KUALA LUMPUR (Reuters) - Malaysia has given conditional approval for a COVID-19 vaccine made through China's Sinovac for use on younger americans aged between 12 and 17, its fitness ministry said on Friday.
young adults more youthful than 18 began receiving COVID-19 doses remaining month, after vaccinations of more than 80% of adults have been completed in one of Southeast Asia's fastest vaccine rollouts that has covered 62% of a population of 32 million.
In a press release, the health ministry talked about Malaysia's drugs regulator advised priority for Sinovac's product amongst teenagers devoid of co-morbidities or allergic reaction problems, or otherwise deemed unsuitable for the Pfizer-BioNTech vaccine.
In July, Malaysia stated it might stop https://www.reuters.com/world/asia-pacific/malaysia-stop-using-sinovac-vaccine-after-supply-ends-minister-2021-07-15 giving the Sinovac shot when resources ran out, as it had satisfactory of other vaccines for the country wide campaign.
Malaysia has persisted to obtain extra shipments, besides the fact that children. This week, the foreign ministry stated China had agreed to donate 1,000,000 doses of the Sinovac vaccine, following a donation of 500,000 in July.
(Reporting by using Rozanna Latiff; enhancing by way of Clarence Fernandez)
0 Comments